Advancing differentiated MC4R-based obesity programs into clinical development Melanocortin-based obesity therapies targeting rare MC4R pathway disorders with a primary ...

It’s not in your stomach; it’s in your head. Scientists have mapped exactly how cannabis overrides your brain's satiety ...

New Cell-Based Assay Supports Drug Discovery Targeting Appetite Regulation, Stress Biology, and Autonomic Function ...

Social media may glamorize athletes’ diets, but restrictive eating combined with intense training can produce low energy availability, menstrual dysfunction, and bone loss in female competitors.

Palatin Technologies, Inc. , a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system, today announced ...

New research identifies the SNAP-47 protein as the key regulator of slow oxytocin release, maintaining the brain's "social vibe." ...

Researchers found that the munchies are a cognitive response that occurs regardless of sex, age, weight or recent food ...

DoD-Funded Study Accelerates Novel PTSD Mechanism into Trials; Proven Alcohol Safety Profile De-Risks Program for ...

Scientists have identified nanoscale lymphatic-like vessels - a network that may help explain how fluids and waste move through brain tissue.

Clinicians warn that GLP-1 treatment often ends within a year and can lead to rapid weight regain; experts urge personalized nutrition, behavioral care, and continued research.

Despite a significant net loss, Palatin Technologies Inc (PTN) strengthens its financial position with a successful public ...

The urgent onset of "the munchies" after cannabis use isn't imaginary—it's a cognitive response that occurs regardless of sex, age, weight or recent food consumption and could offer clues to help ...